Actavis is one of the world's leading players in the development, manufacture, and sale of first-class generic pharmaceuticals. Founded in 1956, the Company has led an assertive programme of expansion, making more than 20 acquisitions in the past seven years while maintaining strong organic growth. The Group has approximately 11,000 employees operating in about 40 countries around the globe. Actavis’ headquarters are in Iceland. The Maltese operation alone boasts a workforce of no less than 550 highly skilled employees.